Immunotherapy for Prostate Cancer: An Emerging Treatment Modality

Charles G. Drake

Research output: Contribution to journalArticlepeer-review

Abstract

This article examines prostate cancer as a target for immunotherapy and investigates active immunotherapy for prostate cancer, combining conventional therapy with active immunotherapy, immune modulators (brakes and accelerators), and monoclonal antibodies.

Original languageEnglish (US)
Pages (from-to)121-129
Number of pages9
JournalUrologic Clinics of North America
Volume37
Issue number1
DOIs
StatePublished - Feb 2010

Keywords

  • CTLA4
  • Lymphocyte
  • PD-1
  • Prostate cancer
  • T cell
  • Vaccine

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Immunotherapy for Prostate Cancer: An Emerging Treatment Modality'. Together they form a unique fingerprint.

Cite this